A landmark lawsuit against Merck is underway in a Los Angeles courtroom, marking the company’s first jury trial over claims it misrepresented the safety of its highly profitable Gardasil HPV vaccine.
Newly declassified documents in the trial have revealed troubling details about Merck’s failure to conduct key safety tests.
